Literature DB >> 1720800

Surgical treatment of pancreatic cancer. The United States experience.

E H Livingston1, M L Welton, H A Reber.   

Abstract

About 28,000 new cases of pancreatic cancer are diagnosed yearly in the United States. The diagnosis is now made up to two months more quickly than just a few years ago, but this has had no impact on survival. In most institutions, 20-25% of patients have resectable lesions. The standard operation is still the Whipple pancreaticoduodenectomy, but many surgeons now use the pylorus preserving modification of that procedure. The operative mortality rate has fallen to less than 5%. The five-year survival rate after a resection for attempted cure is about 9%. Palliation requires cholecysto(docho)jejunostomy and gastrojejunostomy, which is often done prophylactically. The operative mortality rate in patients undergoing palliation is less than 10% (recent UCLA experience), and the average survival is seven months.

Entities:  

Mesh:

Year:  1991        PMID: 1720800     DOI: 10.1007/bf02925591

Source DB:  PubMed          Journal:  Int J Pancreatol        ISSN: 0169-4197


  5 in total

1.  Palliative operations for pancreatic carcinoma.

Authors:  J R Potts; T A Broughan; R E Hermann
Journal:  Am J Surg       Date:  1990-01       Impact factor: 2.565

2.  Gastrojejunostomy: is it helpful for patients with pancreatic cancer?

Authors:  D W Weaver; R G Wiencek; D L Bouwman; A J Walt
Journal:  Surgery       Date:  1987-10       Impact factor: 3.982

3.  Surgical palliation for pancreatic cancer. The UCLA experience.

Authors:  S M Singh; W P Longmire; H A Reber
Journal:  Ann Surg       Date:  1990-08       Impact factor: 12.969

4.  Preoperative staging and assessment of resectability of pancreatic cancer.

Authors:  A L Warshaw; Z Y Gu; J Wittenberg; A C Waltman
Journal:  Arch Surg       Date:  1990-02

5.  Combination therapy for resectable and unresectable adenocarcinoma of the pancreas.

Authors:  R E Falk; F L Moffat; M Lawler; J Heine; L Makowka; J A Falk
Journal:  Cancer       Date:  1986-02-01       Impact factor: 6.860

  5 in total
  20 in total

Review 1.  Adjuvant therapy in pancreatic cancer.

Authors:  P Ghaneh; J Slavin; R Sutton; M Hartley; J P Neoptolemos
Journal:  World J Gastroenterol       Date:  2001-08       Impact factor: 5.742

2.  Guidelines for the management of patients with pancreatic cancer periampullary and ampullary carcinomas.

Authors: 
Journal:  Gut       Date:  2005-06       Impact factor: 23.059

Review 3.  Diagnostic accuracy of different imaging modalities following computed tomography (CT) scanning for assessing the resectability with curative intent in pancreatic and periampullary cancer.

Authors:  Domenico Tamburrino; Deniece Riviere; Mohammad Yaghoobi; Brian R Davidson; Kurinchi Selvan Gurusamy
Journal:  Cochrane Database Syst Rev       Date:  2016-09-15

4.  p16INK4a is a prognostic marker in resected ductal pancreatic cancer: an analysis of p16INK4a, p53, MDM2, an Rb.

Authors:  Berthold Gerdes; Annette Ramaswamy; Andreas Ziegler; Sven A Lang; Michael Kersting; Renate Baumann; Anja Wild; Roland Moll; Matthias Rothmund; Detlef K Bartsch
Journal:  Ann Surg       Date:  2002-01       Impact factor: 12.969

5.  Magnetic resonance angiography in the resectability assessment of suspected pancreatic tumours.

Authors:  O Smedby; V Riesenfeld; B Karlson; G Jacobson; A Löfberg; P G Lindgren; H Ahlström
Journal:  Eur Radiol       Date:  1997       Impact factor: 5.315

Review 6.  Adjuvant chemotherapy in pancreatic cancer.

Authors:  S R Bramhall; J P Neoptolemos
Journal:  Int J Pancreatol       Date:  1997-02

7.  Prognostic implication of para-aortic lymph node metastasis in resectable pancreatic cancer.

Authors:  Ryuichiro Doi; Kazuhiro Kami; Daisuke Ito; Koji Fujimoto; Yoshiya Kawaguchi; Michihiko Wada; Masafumi Kogire; Ryo Hosotani; Masayuki Imamura; Shinji Uemoto
Journal:  World J Surg       Date:  2007-01       Impact factor: 3.352

8.  Investigational Strategies for Detection and Intervention in Early-Stage Pancreatic Cancer. April 24-27, Annapolis, Maryland. Abstracts.

Authors: 
Journal:  Int J Pancreatol       Date:  1994 Oct-Dec

9.  Surgery versus radiochemotherapy for resectable locally invasive pancreatic cancer: final results of a randomized multi-institutional trial.

Authors:  Ryuichiro Doi; Masayuki Imamura; Ryo Hosotani; Toshihide Imaizumi; Takashi Hatori; Ken Takasaki; Akihiro Funakoshi; Hideyuki Wakasugi; Takehide Asano; Shoichi Hishinuma; Yoshiro Ogata; Makoto Sunamura; Koji Yamaguchi; Masao Tanaka; Sonshin Takao; Takashi Aikou; Koichi Hirata; Hiroyuki Maguchi; Koichi Aiura; Tatsuya Aoki; Akira Kakita; Makoto Sasaki; Masahiko Ozaki; Satoru Matsusue; Shunichi Higashide; Hideki Noda; Seiyo Ikeda; Shunzo Maetani; Shigeaki Yoshida
Journal:  Surg Today       Date:  2008-10-29       Impact factor: 2.549

10.  The PMAIP1 gene on chromosome 18 is a candidate tumor suppressor gene in human pancreatic cancer.

Authors:  Masaharu Ishida; Makoto Sunamura; Toru Furukawa; Liviu P Lefter; Rina Morita; Masanori Akada; Shinichi Egawa; Michiaki Unno; Akira Horii
Journal:  Dig Dis Sci       Date:  2008-01-31       Impact factor: 3.199

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.